The CC Treatment uses Superoxide Dismutase as a Target for the Selective Killing of Cancer Cells

The topic of Superoxide Dismutase (SOD) as a target for the selective killing of cancer cells was published in the US Library of Medicine in 2001 by the Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. Now almost 12 years later the Superoxide Dismutase – SOD is one of the technologies in the invention of the CC Formula as described in several areas of the patent filings. Continue reading